Ticker: DOCU

DocuSign

Software Technology Software - Application

Price 84.89

Reco Buy Potential 75 Risk 30 Updated 2026-10-27

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

DocuSign provides electronic signature technology and digital transaction management services. Its core products include e-signature solutions, which facilitate the signing of documents online, and a suite of tools for managing agreements. Major business segments encompass real estate, financial services, and healthcare, with primary revenue sources derived from subscription fees for its software and services. The company serves a diverse clientele, ranging from small businesses to large enterprises, enhancing operational efficiency and compliance in document management.

Investment Profile

The investment profile of DocuSign is more aligned with growth investors, given its focus on expanding its digital solutions in a rapidly evolving market. The company shows potential for revenue growth, although it carries a higher risk profile due to market volatility. Investors seeking a balanced approach may also find it suitable, as it offers opportunities for capital appreciation.

Category: Software Sector: Technology Industry: Software - Application Investment style: Growth Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-10-25

EPS (TTM) — earnings per share for the last 12 months, $: 1.67
Revenue QoQ — quarter-over-quarter revenue growth: 5.5%
EPS surprise: 6.4%
20d volatility: 2.2%

AI recommendation changes

Date	Before	After	Reason
2026-10-05	Hold	Buy	Strong momentum, but cautious due to market conditions.
2026-09-28	Buy	Hold	Positive revenue growth, but mixed momentum signals.
2026-09-21	Hold	Buy	Strong momentum, but cautious on valuation and market conditions.
2026-09-14	Buy	Hold	Mixed performance; cautious outlook amid market volatility.
2026-08-29	Hold	Buy	Positive momentum but mixed fundamentals warrant caution.
2026-08-11	Buy	Hold	Mixed signals; monitor for improved fundamentals and momentum.
2026-08-02	Hold	Buy	Strong momentum, but fundamentals show slight weakness.
2026-07-25	Sell	Hold	Mixed momentum; fundamentals show slight weakness.
2026-07-23	Buy	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-07-17	Hold	Buy	Strong recent performance and positive EPS surprise.
2026-07-07	Sell	Hold	Weak fundamentals and high risk limit upside potential.
2026-06-09	Hold	Sell	Weak fundamentals and negative momentum signal high risk.
2026-06-05	Sell	Hold	Weak momentum and high risk limit upside potential.
2026-05-28	Hold	Sell	Weak momentum and high risk limit upside potential.
2026-05-08	—	Hold	Mixed performance; cautious due to high risk factors.
2026-05-04	Sell	Hold	Компания показывает умеренный рост за последние дни, но значительное падение за последние 120 дней указывает на высокие риски. Рекомендуется удерживать акции до более ясных сигналов о восстановлении.
2026-04-19	Hold	Sell	Компания показывает смешанные результаты: недавний рост на 5 дней, но значительное падение за более длительные периоды. Рекомендуется удерживать акции до более ясных сигналов о восстановлении.
2026-04-11	Sell	Hold	Компания испытывает значительное снижение цен акций за последние месяцы, что указывает на слабый спрос и высокие риски. Низкий рост выручки и высокая волатильность также не способствуют положительному прогнозу.
2026-03-16	Hold	Sell	Компания Docusign демонстрирует смешанные результаты, с недавним ростом за 20 дней, но значительным падением за более длительные периоды. Рекомендуется удерживать акции до более ясных сигналов о восстановлении.
2026-03-07	Sell	Hold	Компания показывает положительную динамику за последние дни, но значительное снижение на более длительных интервалах вызывает опасения. Рекомендуется удерживать акции до ясности в тренде.
2026-01-30	Hold	Sell	Компания демонстрирует значительное снижение цен на акции за последние месяцы, что указывает на слабый спрос и высокие риски. EPS и рост выручки остаются положительными, но текущая динамика цен вызывает опасения.
2026-01-23	Sell	Hold	Компания DOCU демонстрирует негативные тренды на краткосрочных интервалах, но имеет положительные показатели EPS и рост выручки. Рекомендуется держать акции в ожидании улучшения ситуации.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-09-04	UBS	Target Raised	54 → 70	65.82
2026-09-04	Piper Sandler	Target Raised	52 → 75	65.97
2026-09-04	Robert W. Baird	Target Raised	— → 72	65.97
2026-09-04	Morgan Stanley	Target Raised	— → 75	65.97
2026-09-04	Wells Fargo	Target Raised	— → 60	65.97
2026-09-04	Evercore ISI	Target Raised	— → 65	65.97
2026-09-02	BTIG	Target Raised	60 → 75	64.64
2026-06-05	Wedbush	Target Lowered	60 → 58	47.185
2026-06-05	UBS	Target Lowered	70 → 60	50.94
2026-06-05	Wells Fargo	Target Lowered	— → 55	50.94
2026-02-23	Jefferies	Rating Downgraded	— → 45	44.48
2026-02-18	BTIG	Target Lowered	88 → 70	45.21
2026-02-13	HSBC	Target Lowered	77 → 53	43.74
2026-01-05	RBC Capital	Target Lowered	95 → 70	64.85
2025-12-16	BTIG	Update	— → 88	67.58
2025-12-05	Evercore ISI	Target Lowered	92 → 80	66.08
2025-12-05	UBS	Target Lowered	85 → 75	66.48
2025-12-05	RBC Capital	Update	— → 95	66.66
2025-12-05	Wedbush	Target Lowered	85 → 75	71.1
2025-12-05	Robert W. Baird	Target Lowered	90 → 75	71.1

News Page 1 of 1

AI Safety Debate Highlights Challenges at Salesforce’s Dreamforce Conference

09/18/2026, 04:38 AM economy review ai software Nice Nvidia DocuSign Salesforce

At Salesforce's Dreamforce conference, discussions highlighted a disconnect between the rapid advancements in AI technology and the current capabilities that businesses are utilizing, suggesting that many companies are still relying on older models rather than the latest innovations. This reflects a cautious approach to AI adoption amid ongoing safety debates in the industry.

Lululemon Athletica (LULU) shares plummet 18% following disappointing earnings forecast, while Docusign (DOCU) rises over 4% on strong quarterly results

09/03/2026, 04:36 PM review Lululemon DocuSign

Lululemon Athletica's shares plummeted 18% following a disappointing earnings forecast, while Docusign's stock rose over 4% after exceeding earnings expectations and raising its revenue guidance.

Market Movers: Weekly Jobless Claims and Earnings Reports to Influence Trading Session

09/02/2026, 05:36 PM investing review Uber Technologies Lululemon DocuSign Campbell Soup Company Tesla Hewlett Packard Enterprise

Investors should pay attention to upcoming earnings reports and economic indicators, as these could significantly influence market movements in the near term.

Stocks Making Significant Moves Premarket: Lululemon, Micron, ServiceTitan, and More

06/05/2026, 05:34 AM business review Micron Advanced Micro Devices Chipotle Mexican Grill Lululemon DocuSign Intel Cooper Companies Broadcom Lam Research

Lululemon Athletica's shares dropped 13% after the company lowered its earnings and revenue guidance, indicating broader challenges in the retail sector. This decline, along with mixed performances from other companies, highlights ongoing volatility in the market, particularly in the tech and chip sectors.

Stocks Making Significant After-Hours Moves: Lululemon Athletica, ServiceTitan, Argan, and Others

06/04/2026, 02:31 PM business review Lululemon DocuSign Cooper Companies

Several companies experienced significant stock movements after hours, with Lululemon and Guidewire facing declines due to disappointing earnings guidance, while ServiceTitan and Argan saw gains after exceeding expectations.